Thrive Capital Management (Pennsylvania)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Buy
16,941
+2,301
+16% +$637K 0.71% 67
2026
Q1
$4.32M Sell
14,640
-601
-4% -$179K 0.95% 29
2025
Q4
$4.16M Sell
15,241
-191
-1% -$51.9K 0.93% 37
2025
Q3
$4.17M Buy
15,432
+3,903
+34% +$1.06M 1.08% 29
2025
Q2
$3.18M Buy
11,529
+4,832
+72% +$1.31M 1% 40
2025
Q1
$1.78M Sell
6,697
-3,843
-36% -$948K 1.06% 20
2024
Q4
$2.45M Buy
10,540
+1,866
+22% +$429K 1.12% 32
2024
Q3
$1.91M Buy
+8,674
New +$1.79M 0.9% 33

Other funds holding CME

Thrive Capital Management (Pennsylvania)'s CME Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its CME Group (CME) stake by 16% in Q2 2026, buying an estimated $637K and bringing the position to 16,941 shares worth $3.74M. The position accounts for 0.71% of the portfolio, ranked #67.

Thrive Capital Management (Pennsylvania) first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.32M in Q1 2026. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 16,941 shares of CME Group worth $3.74M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 2,301 CME Group shares in Q2 2026, an estimated $637K.
  • CME Group made up 0.71% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #67 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • Thrive Capital Management (Pennsylvania)'s CME Group position peaked at $4.32M in Q1 2026.
  • 1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.